Catalog No.
EHC90701
Expression system
Mammalian Cells
Species
Homo sapiens (Human)
Protein length
Glu213-Pro297
Predicted molecular weight
11.01 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P11836
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
B-lymphocyte surface antigen B1, Membrane-spanning 4-domains subfamily A member 1, MS4A1, Leukocyte surface antigen Leu-16, B-lymphocyte antigen CD20, Bp35, CD20
Case Report: Flow cytometric differential diagnosis of a peripheral T-cell lymphoma, NOS with complete loss of CD45 and dim expression of CD3., PMID:40510503
The immunology and neuropathology of the autoimmune nodopathies., PMID:40505341
QSP modeling of loncastuximab tesirine with T-cell-dependent bispecific antibodies guides dose-regimen strategy., PMID:40500294
Immunosuppressive agents in diabetes treatment: Hope or despair?, PMID:40487626
Primary Mediastinal Large B-cell Lymphoma: A Diagnostic Conundrum., PMID:40487560
Potential use of the SARS-CoV-2 monoclonal antibody sipavibart in people with multiple sclerosis: definition of different patient archetypes from an Italian expert group perspective., PMID:40481170
CD20×CD3 Bispecific Antibodies in B-NHL: A Review of Translational Science, Pharmacokinetics, Pharmacodynamics, and Dose Strategy in Clinical Research., PMID:40471801
Peripheral memory B cell population maintenance and long-term survival after perioperative chemoimmunotherapy in NSCLC (NADIM trial)., PMID:40468805
Predictive factors and nomogram for the risk of cytokine release syndrome with anti-CD3 × CD20 bispecific antibodies for Chinese patients., PMID:40464994
Pathogenesis, Diagnosis, Treatment, and Prognosis of CD20-Positive T and NK Cell Lymphoma: A Review., PMID:40460386
Recent advances in monoclonal antibody development for treatment of B-cell acute lymphoblastic leukemia., PMID:40455243
Rituximab Use for Relapse Prevention in Anti-NMDAR Antibody-Mediated Encephalitis: A Multicenter Cohort Study., PMID:40446185
Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study., PMID:40442445
Efficacy and safety of CD19 combined with CD22 or CD20 chimeric antigen receptor T-cell therapy for hematological malignancies., PMID:40433368
Dysregulated Adaptive Immune Responses to SARS-CoV-2 in Immunocompromised Individuals., PMID:40431250
Intravascular Large B-Cell Lymphoma Diagnosed After Recurrent Stroke: Case Report and Literature Review., PMID:40423224
Case Report: Bispecific CD20/CD30-targeted chimeric antigen receptor T-cell therapy for non-Hodgkin's lymphoma., PMID:40406106
Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosis., PMID:40402264
CD2AP shapes a stromal reduced tumor microenvironment and contributes to immunotherapy in gastric cancer., PMID:40399857
Immune dysregulation in endometrial tuberculosis: elevated HLA-G and IL-1Ra as key modulators., PMID:40375897
Early caplacizumab and obinutuzumab enable successful treatment of relapsing thrombotic thrombocytopenic purpura without therapeutic plasma exchange: a case report., PMID:40356910
Paricalcitol promotes the maturation of immune granulomas in an experimental model of superoxide dismutase A-induced inflammation., PMID:40355595
Case report on severe myelin oligodendrocyte glycoprotein antibody-associated disease relapse after ectopic pregnancy and laparoscopic medical abortion: relevance of peripheral inflammation for demyelinating disease activity., PMID:40352936
Chimeric antigen receptor (CAR) T-cell therapy-related gastrointestinal toxicity: Histologic features and morphologic mimics., PMID:40349988
Monoclonal gammopathy-associated C3 glomerulonephritis secondary to follicular lymphoma: a case report., PMID:40342409
Cell therapy with placenta-derived mesenchymal stem cells for secondary progressive multiple sclerosis patients in a phase 1 clinical trial., PMID:40341605
Interventions for idiopathic steroid-resistant nephrotic syndrome in children., PMID:40337980
Waldenström Macroglobulinemia Diagnosed by Ultrasonography-Guided Biopsy of the Right Perinephric Tumor., PMID:40336752
New Frontiers in Multiple Sclerosis Treatment: From Targeting Costimulatory Molecules to Bispecific Antibodies., PMID:40332536
[Screening of the specific aptamer of human CD20 extracellular protein expressed in Escherichia coli by systematic evolution of ligands by exponential enrichment]., PMID:40328709
The efficacy and safety of rituximab monotherapy in the new onset pediatric idiopathic nephrotic syndrome: a randomized controlled clinical trial., PMID:40328661
A Case Report of Sustained Cytokine Release Syndrome Due to Glofitamab and Literature Review., PMID:40322275
Comprehensive analysis of B cell repopulation in ocrelizumab-treated patients with multiple sclerosis by mass cytometry and proteomics., PMID:40322080
[Seronegativity and anti-CD20: When a treatment compromises the diagnosis]., PMID:40312237
The bispecific antibody AZD0486: an overview of the clinical journey to date with a focus on follicular lymphoma., PMID:40312112
Obinutuzumab for treatment of membranous nephropathy in patients positive and negative for the phospholipase A2 receptor antibody: case reports., PMID:40303416
Pathological and clinical insights into DICER1 hotspot mutated Sertoli-Leydig cell tumors: a comparative analysis., PMID:40301978
N-terminal truncation of STAT1 transcription factor causes CD3- and CD20-negative non-Hodgkin lymphoma through upregulation of STAT3-mediated oncogenic functions., PMID:40287766
Pathological Study on Trigeminal Ganglionitis Among Rabid Dogs in the Philippines., PMID:40284801
Identifying Modifiers of CAR T-Cell Therapeutic Efficacy and Safety: A Systematic Review and Individual Patient Data Meta-Analysis., PMID:40280037
Ethnic Sensitivity Assessment of Mosunetuzumab Pharmacokinetics and Pharmacodynamics in Chinese Patients With Relapsed or Refractory Follicular Lymphoma., PMID:40279333
Treatment outcomes of BTK inhibitors and venetoclax with or without anti-CD20 monoclonal antibody in relapsed or refractory mantle cell lymphoma., PMID:40278919
Gastric SMARCA4-deficient undifferentiated tumors: clinicopathological analysis of two cases in a single center., PMID:40275321
CD20 xCD3 bispecific antibodies for large B cell lymphoma: latest updates from 2024 ASH annual meeting., PMID:40264167
Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series., PMID:40255393
Rituximab-induced serum sickness in progressive transformation of germinal centers immunoglobulin G4-related disease: a case report., PMID:40253385
CD5 and p53 immunohistochemistry: valuable prediction method in molecular typing of CD5-positive diffuse large B-cell lymphoma., PMID:40247210
PD-L1-Targeting Nanoparticles for the Treatment of Triple-Negative Breast Cancer: A Preclinical Model., PMID:40244130
CD70 recruitment to the immunological synapse is dependent on CD20 in B cells., PMID:40232798
B cell depletion in lupus nephritis: From disappointments to hopes, despite some concerns., PMID:40220749
For research use only. Not for human or drug use.
